COBICISTAT

COBICISTAT was reported 10045 times

COBICISTAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FLOPPY EYELID SYNDROME 5 0.1429
1 VULVOVAGINITIS ALLERGIC 1 0.1429
2 CONGENITAL INTESTINAL MALFORMATION 12 0.1034
3 FOETAL GROWTH ABNORMALITY 15 0.0955
4 ANAL CHLAMYDIA INFECTION 1 0.0833
5 DRUG TROUGH LEVEL 3 0.0732
6 PENOSCROTAL TRANSPOSITION 1 0.0714
7 PERINATAL HIV INFECTION 1 0.0714
8 TERTIARY ADRENAL INSUFFICIENCY 3 0.0556
9 DISSEMINATED TRICHOSPORONOSIS 3 0.0417
10 LYMPHANGIECTASIA INTESTINAL 2 0.0400
11 GASTROSCHISIS 16 0.0336
12 PSYCHOTHERAPY 1 0.0333
13 LYMPHANGIECTASIA 2 0.0286
14 RENAL DYSPLASIA 11 0.0284
15 PULMONARY SEQUESTRATION 1 0.0182
16 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 2 0.0180
17 LIPOEDEMA 7 0.0178
18 SINGLE FUNCTIONAL KIDNEY 11 0.0166
19 CONGENITAL URETERIC ANOMALY 1 0.0161
20 CHOLESTASIS OF PREGNANCY 7 0.0152
21 HELLP SYNDROME 7 0.0114
22 RENAL APLASIA 8 0.0114
23 DRUG RESISTANCE MUTATION 2 0.0112
24 PENICILLIUM INFECTION 2 0.0111
25 COELIAC ARTERY STENOSIS 1 0.0110
26 RENAL TUBULAR DYSFUNCTION 6 0.0106
27 GASTROENTERITIS CRYPTOSPORIDIAL 2 0.0099
28 LYMPH NODE ABSCESS 1 0.0098
29 EXTRAOCULAR MUSCLE DISORDER 3 0.0093
30 AMNIOTIC BAND SYNDROME 1 0.0091
31 FLUID INTAKE RESTRICTION 1 0.0091
32 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0090
33 VERTICAL INFECTION TRANSMISSION 1 0.0088
34 FOETAL EXPOSURE DURING DELIVERY 6 0.0088
35 FIBROUS HISTIOCYTOMA 3 0.0085
36 HYPERPHOSPHATURIA 1 0.0085
37 LIPODYSTROPHY ACQUIRED 18 0.0085
38 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 3 0.0084
39 MESENTERIC ARTERY STENOSIS 1 0.0082
40 ARRHYTHMIA NEONATAL 1 0.0081
41 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 1 0.0078
42 BLIGHTED OVUM 3 0.0076
43 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 38 0.0076
44 CHORDEE 1 0.0071
45 FEAR-RELATED AVOIDANCE OF ACTIVITIES 1 0.0066
46 CAUDAL REGRESSION SYNDROME 1 0.0064
47 LIP DISCOLOURATION 8 0.0063
48 SPINA BIFIDA 13 0.0062
49 DYSDIADOCHOKINESIS 1 0.0058
50 MENINGOENCEPHALITIS VIRAL 1 0.0056
51 T-LYMPHOCYTE COUNT INCREASED 1 0.0054
52 HERPES SIMPLEX REACTIVATION 2 0.0052
53 POSTPARTUM HAEMORRHAGE 7 0.0052
54 HIV VIRAEMIA 1 0.0048
55 CRYSTAL DEPOSIT INTESTINE 1 0.0047
56 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 5 0.0045
57 VIROLOGIC FAILURE 24 0.0045
58 FAT REDISTRIBUTION 1 0.0043
59 COCCIDIOIDOMYCOSIS 5 0.0042
60 ULNAR NERVE INJURY 1 0.0041
61 SCHIZOPHRENIFORM DISORDER 1 0.0041
62 PROTEIN-LOSING GASTROENTEROPATHY 2 0.0040
63 CENTRAL NERVOUS SYSTEM VASCULITIS 2 0.0039
64 CONGENITAL HYPOTHYROIDISM 1 0.0039
65 STEATOHEPATITIS 2 0.0037
66 BODY FAT DISORDER 2 0.0037
67 LEISHMANIASIS 1 0.0034
68 CATHETER SITE HAEMATOMA 1 0.0034
69 SECONDARY ADRENOCORTICAL INSUFFICIENCY 5 0.0033
70 BLOOD HIV RNA INCREASED 6 0.0033
71 NEONATAL BEHAVIOURAL SYNDROME 1 0.0033
72 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
73 LIPOHYPERTROPHY 2 0.0032
74 GENE MUTATION 6 0.0030
75 CENTRAL NERVOUS SYSTEM INFLAMMATION 1 0.0030
76 SOFT TISSUE INFLAMMATION 1 0.0030
77 RECTAL CANCER METASTATIC 1 0.0029
78 BONE DEMINERALISATION 3 0.0028
79 ALCOHOL INTOLERANCE 2 0.0028
80 BLOOD BILIRUBIN UNCONJUGATED INCREASED 2 0.0028
81 SYPHILIS 2 0.0028
82 GRANDIOSITY 1 0.0027
83 ADRENAL INSUFFICIENCY 32 0.0026
84 HYDROCEPHALUS 14 0.0026
85 CONGENITAL DIAPHRAGMATIC HERNIA 1 0.0026
86 HEMIANAESTHESIA 2 0.0025
87 FOETAL GROWTH RESTRICTION 15 0.0025
88 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
89 ADRENAL SUPPRESSION 2 0.0024
90 CD4 LYMPHOCYTES DECREASED 5 0.0023
91 FOETAL DEATH 12 0.0023
92 TOXIC OPTIC NEUROPATHY 1 0.0023
93 EXPOSURE VIA FATHER 3 0.0023
94 HAEMANGIOMA OF SKIN 1 0.0023
95 HISTOPLASMOSIS 4 0.0023
96 MUSCLE MASS 1 0.0022
97 CUSHINGOID 7 0.0022
98 VIRAL MUTATION IDENTIFIED 8 0.0022
99 PRIMARY BILIARY CHOLANGITIS 1 0.0021
100 LABELLED DRUG-DRUG INTERACTION ISSUE 3 0.0021
101 FAT TISSUE INCREASED 3 0.0021
102 NAIL DISCOLOURATION 8 0.0020
103 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 1 0.0020
104 ILEAL ULCER 2 0.0020
105 GENOTYPE DRUG RESISTANCE TEST POSITIVE 2 0.0019
106 DRUG LEVEL ABNORMAL 1 0.0019
107 SEROTONIN SYNDROME 36 0.0019
108 BLOOD TESTOSTERONE ABNORMAL 2 0.0018
109 ANENCEPHALY 1 0.0018
110 MECHANICAL ILEUS 1 0.0018
111 CORTISOL DECREASED 2 0.0017
112 HYPERBILIRUBINAEMIA NEONATAL 1 0.0017
113 BRAIN INJURY 17 0.0017
114 GASTROINTESTINAL OBSTRUCTION 4 0.0017
115 ATYPICAL FRACTURE 1 0.0016
116 PREMATURE LABOUR 9 0.0016
117 BREECH PRESENTATION 2 0.0016
118 VIRAL LOAD INCREASED 6 0.0015
119 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
120 ILEAL PERFORATION 1 0.0015
121 PRE-ECLAMPSIA 7 0.0015
122 VISCERAL LEISHMANIASIS 1 0.0014
123 HAEMORRHAGIC TRANSFORMATION STROKE 2 0.0013
124 HIV INFECTION 4 0.0013
125 CHRONIC HEPATITIS 1 0.0012
126 MITOCHONDRIAL TOXICITY 1 0.0012
127 QUADRIPARESIS 2 0.0012
128 ENDOCRINE OPHTHALMOPATHY 1 0.0012
129 DRUG INTERACTION 181 0.0011
130 FANCONI SYNDROME ACQUIRED 2 0.0011
131 ANOGENITAL WARTS 1 0.0011
132 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
133 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 9 0.0011
134 RENAL TUBULAR DISORDER 3 0.0011
135 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
136 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
137 LOW BIRTH WEIGHT BABY 8 0.0010
138 GASTRECTOMY 1 0.0010
139 PATHOGEN RESISTANCE 9 0.0010
140 INJECTION SITE NECROSIS 2 0.0010
141 RETINAL TOXICITY 1 0.0010
142 MULTIPLE-DRUG RESISTANCE 3 0.0010
143 BONE MARROW OEDEMA 1 0.0010
144 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
145 EYELID PTOSIS 9 0.0009
146 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
147 PELVIC ABSCESS 1 0.0009
148 CYTOMEGALOVIRUS COLITIS 2 0.0009
149 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
150 POLYDACTYLY 1 0.0009
151 GROIN ABSCESS 1 0.0008
152 GASTROINTESTINAL TUBE INSERTION 2 0.0008
153 TRISOMY 21 1 0.0008
154 MICROCEPHALY 1 0.0008
155 APGAR SCORE LOW 1 0.0008
156 DRUG CLEARANCE DECREASED 1 0.0008
157 ANHEDONIA 20 0.0008
158 HIRSUTISM 1 0.0008
159 SHOULDER ARTHROPLASTY 2 0.0007
160 THROMBOCYTOPENIC PURPURA 1 0.0007
161 MENINGITIS VIRAL 1 0.0007
162 RENAL ARTERY STENOSIS 1 0.0007
163 NERVE INJURY 8 0.0007
164 NORMOCYTIC ANAEMIA 1 0.0007
165 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 6 0.0007
166 HYPOPHOSPHATAEMIA 5 0.0007
167 SKIN STRIAE 1 0.0007
168 MENTAL FATIGUE 1 0.0007
169 DRUG LEVEL INCREASED 11 0.0007
170 OSTEOPENIA 10 0.0007
171 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
172 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
173 ORAL MUCOSAL ERUPTION 1 0.0007
174 OSTEOMALACIA 1 0.0006
175 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
176 KERATOPATHY 1 0.0006
177 SARCOIDOSIS 3 0.0006
178 OPTIC ATROPHY 1 0.0006
179 DEAFNESS NEUROSENSORY 2 0.0006
180 SMALL FOR DATES BABY 3 0.0006
181 PNEUMONIA ASPIRATION 15 0.0006
182 POTENTIATING DRUG INTERACTION 2 0.0006
183 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
184 FOETAL EXPOSURE DURING PREGNANCY 48 0.0006
185 LEFT VENTRICULAR FAILURE 2 0.0006
186 CHOREA 1 0.0006
187 MYOPATHY 5 0.0006
188 HYPERREFLEXIA 2 0.0006
189 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
190 CEREBRAL VENOUS THROMBOSIS 1 0.0006
191 VULVOVAGINAL SWELLING 1 0.0005
192 MAJOR DEPRESSION 4 0.0005
193 HOMICIDE 1 0.0005
194 ECONOMIC PROBLEM 8 0.0005
195 OSTEOPOROTIC FRACTURE 1 0.0005
196 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
197 HYPERAEMIA 1 0.0005
198 PRODUCT PRESCRIBING ERROR 12 0.0005
199 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
200 HEPATITIS B 3 0.0005
201 MICROCYTIC ANAEMIA 1 0.0005
202 SLEEP DEFICIT 1 0.0005
203 METABOLIC ACIDOSIS 15 0.0005
204 ORTHOSTATIC HYPOTENSION 8 0.0005
205 RENAL TUBULAR ACIDOSIS 1 0.0005
206 CERVICAL DYSPLASIA 1 0.0005
207 CEREBELLAR SYNDROME 1 0.0005
208 MELANOCYTIC NAEVUS 2 0.0005
209 PERIARTHRITIS 1 0.0004
210 DIVERTICULUM 3 0.0004
211 HAEMATOLOGICAL INFECTION 1 0.0004
212 RHABDOMYOLYSIS 17 0.0004
213 SYSTEMIC CANDIDA 1 0.0004
214 CORONARY ARTERY STENOSIS 2 0.0004
215 DYSLIPIDAEMIA 2 0.0004
216 DRUG RESISTANCE 10 0.0004
217 OSTEOPOROSIS 16 0.0004
218 AORTIC ARTERIOSCLEROSIS 1 0.0004
219 MALABSORPTION 2 0.0004
220 RADICULOPATHY 1 0.0004
221 RENAL PAIN 4 0.0004
222 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
223 GASTROINTESTINAL INJURY 1 0.0004
224 DECREASED ACTIVITY 4 0.0004
225 GAMBLING DISORDER 1 0.0004
226 CLONUS 1 0.0004
227 IMMUNE-MEDIATED MYOSITIS 1 0.0004
228 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
229 RASH MORBILLIFORM 1 0.0004
230 ENDOTRACHEAL INTUBATION 1 0.0004
231 NEPHROPATHY TOXIC 4 0.0004
232 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
233 ATYPICAL FEMUR FRACTURE 1 0.0004
234 ABORTION SPONTANEOUS 14 0.0003
235 EXERCISE TOLERANCE DECREASED 2 0.0003
236 COMA SCALE ABNORMAL 1 0.0003
237 METABOLIC DISORDER 2 0.0003
238 LOSS OF EMPLOYMENT 1 0.0003
239 DIABETIC FOOT 1 0.0003
240 DUODENITIS 1 0.0003
241 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
242 ECTOPIC PREGNANCY 1 0.0003
243 HEPATITIS B REACTIVATION 1 0.0003
244 PNEUMONIA VIRAL 1 0.0003
245 TREATMENT NONCOMPLIANCE 17 0.0003
246 PORTAL VEIN THROMBOSIS 1 0.0003
247 VITAMIN D DEFICIENCY 3 0.0003
248 RENAL TUBULAR NECROSIS 3 0.0003
249 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
250 ASPERGILLUS INFECTION 2 0.0003
251 DISABILITY 6 0.0003
252 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
253 POST-TRAUMATIC STRESS DISORDER 2 0.0003
254 HYPERTRANSAMINASAEMIA 2 0.0003
255 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
256 BONE DENSITY ABNORMAL 1 0.0003
257 HYDRONEPHROSIS 2 0.0003
258 CHRONIC SINUSITIS 1 0.0003
259 HYPERTHERMIA 2 0.0003
260 HIP ARTHROPLASTY 4 0.0003
261 CLAVICLE FRACTURE 1 0.0003
262 OESOPHAGEAL ULCER 1 0.0003
263 HYPOALBUMINAEMIA 2 0.0003
264 EPIGASTRIC DISCOMFORT 1 0.0003
265 PROCEDURAL HAEMORRHAGE 1 0.0003
266 COVID-19 PNEUMONIA 3 0.0003
267 OESOPHAGEAL CANDIDIASIS 1 0.0003
268 ORGAN FAILURE 1 0.0002
269 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
270 OSTEONECROSIS 8 0.0002
271 SELF-MEDICATION 1 0.0002
272 MANIA 4 0.0002
273 INTERVERTEBRAL DISC DISORDER 1 0.0002
274 PULMONARY TUBERCULOSIS 1 0.0002
275 PRODUCT DISPENSING ISSUE 1 0.0002
276 PREMATURE BABY 7 0.0002
277 BONE DENSITY DECREASED 7 0.0002
278 MYOSITIS 2 0.0002
279 PAPILLOEDEMA 1 0.0002
280 ABDOMINAL HERNIA 1 0.0002
281 RESPIRATORY DISTRESS 6 0.0002
282 NEPHROGENIC ANAEMIA 1 0.0002
283 APPENDICITIS 2 0.0002
284 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
285 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
286 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
287 EXPOSURE DURING PREGNANCY 13 0.0002
288 LIMB OPERATION 1 0.0002
289 HUMERUS FRACTURE 1 0.0002
290 GUILLAIN-BARRE SYNDROME 1 0.0002
291 HYPERNATRAEMIA 1 0.0002
292 ERYSIPELAS 1 0.0002
293 CHRONIC KIDNEY DISEASE 15 0.0002
294 CORONARY ARTERIAL STENT INSERTION 1 0.0002
295 PATHOLOGICAL FRACTURE 1 0.0002
296 FEMORAL NECK FRACTURE 1 0.0002
297 ENDOCARDITIS 1 0.0002
298 CACHEXIA 1 0.0002
299 HYPERBILIRUBINAEMIA 2 0.0002
300 CATATONIA 1 0.0002
301 POLYARTHRITIS 1 0.0002
302 STRESS FRACTURE 1 0.0002
303 BEHAVIOUR DISORDER 1 0.0002
304 EMOTIONAL DISTRESS 22 0.0002
305 INTRACRANIAL PRESSURE INCREASED 1 0.0002
306 GENERALISED ERYTHEMA 1 0.0002
307 SKIN DISCOLOURATION 8 0.0002
308 SKIN ATROPHY 1 0.0002
309 HYPOVOLAEMIA 1 0.0002
310 HYPERTRIGLYCERIDAEMIA 1 0.0002
311 SPLENOMEGALY 2 0.0002
312 ENERGY INCREASED 1 0.0002
313 BRADYKINESIA 1 0.0002
314 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
315 BACTERAEMIA 2 0.0002
316 HEARING IMPAIRED 1 0.0002
317 RENAL IMPAIRMENT 14 0.0002
318 APHASIA 5 0.0002
319 TENSION 1 0.0002
320 CYTOPENIA 2 0.0002
321 BACTERIAL INFECTION 3 0.0002
322 MUSCLE ATROPHY 2 0.0002
323 ENTERITIS 1 0.0002
324 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
325 HIATUS HERNIA 2 0.0002
326 NODULE 2 0.0002
327 BRADYPHRENIA 1 0.0002
328 SEDATION 4 0.0002
329 EYE DISORDER 5 0.0002
330 QUALITY OF LIFE DECREASED 2 0.0001
331 NEPHROTIC SYNDROME 1 0.0001
332 ECCHYMOSIS 1 0.0001
333 DIABETES MELLITUS 11 0.0001
334 AUTOIMMUNE HEPATITIS 1 0.0001
335 HUNGER 2 0.0001
336 THERMAL BURN 1 0.0001
337 PRODUCT SUPPLY ISSUE 1 0.0001
338 PARALYSIS 2 0.0001
339 IMPAIRED QUALITY OF LIFE 2 0.0001
340 BLOOD CREATININE INCREASED 9 0.0001
341 NEUROPATHY PERIPHERAL 13 0.0001
342 THERAPY NON-RESPONDER 6 0.0001
343 BONE LOSS 2 0.0001
344 PEMPHIGOID 1 0.0001
345 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
346 ACIDOSIS 1 0.0001
347 ACUTE KIDNEY INJURY 20 0.0001
348 ATRIAL FLUTTER 1 0.0001
349 DRUG INTOLERANCE 12 0.0001
350 SENSORY LOSS 1 0.0001
351 RHINITIS 1 0.0001
352 ABNORMAL FAECES 1 0.0001
353 MULTIPLE FRACTURES 2 0.0001
354 HEPATIC ENZYME INCREASED 8 0.0001
355 SKIN HYPERPIGMENTATION 1 0.0001
356 CARDIAC OPERATION 1 0.0001
357 PSYCHOLOGICAL TRAUMA 1 0.0001
358 PYELONEPHRITIS 1 0.0001
359 URINE OUTPUT DECREASED 1 0.0001
360 LUNG INFILTRATION 1 0.0001
361 LYMPHADENOPATHY 4 0.0001
362 OPTIC NEURITIS 1 0.0001
363 END STAGE RENAL DISEASE 2 0.0001
364 PNEUMONIA BACTERIAL 1 0.0001
365 NERVE COMPRESSION 1 0.0001
366 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
367 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
368 FOOT FRACTURE 2 0.0001
369 SLEEP APNOEA SYNDROME 2 0.0001
370 AFFECT LABILITY 1 0.0001
371 PRESCRIBED OVERDOSE 2 0.0001
372 ACUTE MYOCARDIAL INFARCTION 3 0.0001
373 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
374 DRUG LEVEL DECREASED 1 0.0001
375 TOOTH ABSCESS 1 0.0001
376 EPILEPSY 3 0.0001
377 EUPHORIC MOOD 1 0.0001
378 TOOTH LOSS 2 0.0001
379 DRUG-INDUCED LIVER INJURY 3 0.0001
380 WEIGHT FLUCTUATION 1 0.0001
381 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
382 IRRITABLE BOWEL SYNDROME 2 0.0001
383 BIPOLAR DISORDER 1 0.0001
384 ANXIETY 26 0.0001
385 INJECTION SITE NODULE 1 0.0001
386 DEPRESSION 20 0.0001
387 CHOLECYSTECTOMY 1 0.0001
388 MYOCARDITIS 1 0.0001
389 SOMNOLENCE 17 0.0001
390 ATAXIA 1 0.0001
391 MYOCLONUS 1 0.0001
392 POLYNEUROPATHY 1 0.0001
393 MYELOSUPPRESSION 3 0.0001
394 HEPATITIS C 1 0.0001
395 DYSURIA 3 0.0001
396 MUSCLE SPASTICITY 1 0.0001
397 ABNORMAL WEIGHT GAIN 1 0.0001
398 INTENTIONAL PRODUCT MISUSE 7 0.0001
399 DEEP VEIN THROMBOSIS 5 0.0001
400 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
401 GASTRITIS 2 0.0001
402 ADVERSE EVENT 7 0.0001
403 MEMORY IMPAIRMENT 10 0.0001
404 MENTAL STATUS CHANGES 2 0.0001
405 DIALYSIS 1 0.0001
406 SINUS TACHYCARDIA 1 0.0001
407 SEPTIC SHOCK 3 0.0001
408 FLUID OVERLOAD 1 0.0001
409 GASTROENTERITIS 1 0.0001
410 DYSSTASIA 2 0.0001
411 RENAL FAILURE 9 0.0001
412 HAEMORRHAGE 7 0.0001
413 HAEMORRHAGE INTRACRANIAL 1 0.0001
414 HEPATIC FAILURE 2 0.0001
415 NEPHROLITHIASIS 3 0.0001
416 HYPOKALAEMIA 3 0.0001
417 ANKLE FRACTURE 1 0.0001
418 EJECTION FRACTION DECREASED 1 0.0001
419 NERVOUS SYSTEM DISORDER 2 0.0001
420 DYSPHAGIA 6 0.0001
421 ULCER 1 0.0001
422 PREMATURE DELIVERY 1 0.0001
423 OBESITY 1 0.0001
424 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
425 CONTUSION 6 0.0001
426 HIP FRACTURE 2 0.0001
427 SWELLING FACE 4 0.0001
428 STAPHYLOCOCCAL INFECTION 2 0.0001
429 TREATMENT FAILURE 5 0.0001
430 PARANOIA 1 0.0001
431 LOCAL SWELLING 1 0.0001
432 NEUROTOXICITY 1 0.0001
433 EOSINOPHILIA 1 0.0001
434 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
435 DRUG ERUPTION 1 0.0001
436 GOUT 1 0.0001
437 OSTEOMYELITIS 1 0.0001
438 HYPERGLYCAEMIA 2 0.0001
439 DYSARTHRIA 2 0.0001
440 BLOOD URINE PRESENT 1 0.0001
441 PROTEINURIA 1 0.0001
442 LETHARGY 3 0.0001
443 ACUTE RESPIRATORY FAILURE 1 0.0001
444 ABNORMAL BEHAVIOUR 2 0.0001
445 BLOOD PRESSURE ABNORMAL 1 0.0001
446 SPINAL FRACTURE 1 0.0000
447 CYTOKINE RELEASE SYNDROME 1 0.0000
448 THROMBOSIS 4 0.0000
449 PERITONITIS 1 0.0000
450 ROAD TRAFFIC ACCIDENT 2 0.0000
451 DERMATITIS 1 0.0000
452 KNEE ARTHROPLASTY 1 0.0000
453 HALLUCINATION, VISUAL 1 0.0000
454 OSTEOARTHRITIS 2 0.0000
455 IMPAIRED WORK ABILITY 1 0.0000
456 POOR QUALITY SLEEP 1 0.0000
457 FAECES DISCOLOURED 1 0.0000
458 AMNESIA 3 0.0000
459 MYOCARDIAL INFARCTION 8 0.0000
460 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
461 TACHYCARDIA 4 0.0000
462 STEVENS-JOHNSON SYNDROME 1 0.0000
463 TRANSAMINASES INCREASED 1 0.0000
464 RASH MACULO-PAPULAR 1 0.0000
465 CHROMATURIA 1 0.0000
466 PRODUCT AVAILABILITY ISSUE 1 0.0000
467 SHOCK 1 0.0000
468 RENAL DISORDER 2 0.0000
469 PULMONARY EMBOLISM 4 0.0000
470 GAIT DISTURBANCE 8 0.0000
471 TOXICITY TO VARIOUS AGENTS 7 0.0000
472 LOCALISED INFECTION 1 0.0000
473 HYPOGLYCAEMIA 2 0.0000
474 MYALGIA 7 0.0000
475 RESPIRATORY FAILURE 3 0.0000
476 PAIN 25 0.0000
477 LEUKOPENIA 2 0.0000
478 AGGRESSION 2 0.0000
479 CELLULITIS 2 0.0000
480 CARDIOVASCULAR DISORDER 1 0.0000
481 FLUID RETENTION 2 0.0000
482 HYPOPHAGIA 1 0.0000
483 SKIN ULCER 1 0.0000
484 RASH GENERALISED 1 0.0000
485 HAEMATOMA 1 0.0000
486 OEDEMA 2 0.0000
487 ANAEMIA 7 0.0000
488 MOOD ALTERED 1 0.0000
489 ANAPHYLACTIC REACTION 2 0.0000
490 MUSCULAR WEAKNESS 4 0.0000
491 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
492 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
493 MUSCULOSKELETAL STIFFNESS 3 0.0000
494 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
495 PSYCHOTIC DISORDER 1 0.0000
496 OFF LABEL USE 29 0.0000
497 THERAPEUTIC RESPONSE DECREASED 2 0.0000
498 OEDEMA PERIPHERAL 4 0.0000
499 BLOOD PRESSURE INCREASED 5 0.0000
500 DRUG ADMINISTRATION ERROR 1 0.0000
501 FEMUR FRACTURE 1 0.0000
502 SWOLLEN TONGUE 1 0.0000
503 PYREXIA 11 0.0000
504 HEAD INJURY 1 0.0000
505 LACTIC ACIDOSIS 1 0.0000
506 HEART RATE INCREASED 3 0.0000
507 HAEMATURIA 1 0.0000
508 NIGHTMARE 1 0.0000
509 DELIRIUM 1 0.0000
510 BURNING SENSATION 2 0.0000
511 HYPERKALAEMIA 1 0.0000
512 HYPERTENSION 6 0.0000
513 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
514 CRYING 1 0.0000
515 ACCIDENTAL OVERDOSE 1 0.0000
516 INJECTION SITE MASS 1 0.0000
517 BRONCHITIS 2 0.0000
518 SEPSIS 3 0.0000
519 COLITIS 1 0.0000
520 CONDITION AGGRAVATED 8 0.0000
521 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
522 SEIZURE 3 0.0000
523 BACK PAIN 6 0.0000
524 ARTHRITIS 2 0.0000
525 DISORIENTATION 1 0.0000
526 HYPOTENSION 5 0.0000
527 CARDIAC FAILURE 2 0.0000
528 CARDIAC FAILURE CONGESTIVE 2 0.0000
529 NEUTROPHIL COUNT DECREASED 1 0.0000
530 CARDIAC ARREST 2 0.0000
531 POLLAKIURIA 1 0.0000
532 CEREBROVASCULAR ACCIDENT 4 0.0000
533 RENAL FAILURE ACUTE 1 0.0000
534 VOMITING 11 0.0000
535 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
536 ANGIOEDEMA 1 0.0000
537 WEIGHT INCREASED 5 0.0000
538 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
539 NO ADVERSE EVENT 4 0.0000
540 NEUTROPENIA 3 0.0000
541 DIARRHOEA 14 0.0000
542 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
543 CHEST PAIN 4 0.0000
544 DECREASED APPETITE 5 0.0000
545 FEELING ABNORMAL 5 0.0000
546 NAUSEA 16 0.0000
547 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
548 FLUSHING 2 0.0000
549 SINUSITIS 2 0.0000
550 INFLAMMATION 1 0.0000
551 ECZEMA 1 0.0000
552 SPEECH DISORDER 1 0.0000
553 PARAESTHESIA 3 0.0000
554 DRUG INEFFECTIVE 25 0.0000
555 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
556 PLATELET COUNT DECREASED 2 0.0000
557 DEATH 16 0.0000
558 CONFUSIONAL STATE 3 0.0000
559 DEPENDENCE 1 0.0000
560 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
561 HAEMATOCHEZIA 1 0.0000
562 TREMOR 3 0.0000
563 MEDICATION ERROR 1 0.0000
564 INFLUENZA 2 0.0000
565 NECK PAIN 1 0.0000
566 PANCYTOPENIA 1 0.0000
567 THROMBOCYTOPENIA 2 0.0000
568 ASTHMA 2 0.0000
569 URINARY TRACT INFECTION 3 0.0000
570 HERPES ZOSTER 1 0.0000
571 EYE IRRITATION 1 0.0000
572 ABDOMINAL PAIN 4 0.0000
573 DYSPHONIA 1 0.0000
574 CHILLS 2 0.0000
575 SURGERY 1 0.0000
576 ILL-DEFINED DISORDER 1 0.0000
577 VERTIGO 1 0.0000
578 RASH 7 0.0000
579 PRODUCT USE ISSUE 3 0.0000
580 ASTHENIA 6 0.0000
581 LOSS OF CONSCIOUSNESS 2 0.0000
582 HYPERHIDROSIS 2 0.0000
583 ALOPECIA 3 0.0000
584 FEBRILE NEUTROPENIA 1 0.0000
585 INSOMNIA 4 0.0000
586 NEOPLASM MALIGNANT 1 0.0000
587 INJECTION SITE REACTION 1 0.0000
588 SLEEP DISORDER 1 0.0000
589 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
590 MOBILITY DECREASED 1 0.0000
591 INFECTION 2 0.0000
592 AGITATION 1 0.0000
593 HYPOAESTHESIA 2 0.0000
594 INJECTION SITE SWELLING 1 0.0000
595 INJECTION SITE HAEMORRHAGE 1 0.0000
596 INFLUENZA LIKE ILLNESS 1 0.0000
597 DIZZINESS 6 0.0000
598 ARTHRALGIA 5 0.0000
599 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
600 SKIN EXFOLIATION 1 0.0000
601 COVID-19 2 0.0000
602 HEADACHE 7 0.0000
603 GASTROINTESTINAL DISORDER 1 0.0000
604 SUICIDAL IDEATION 1 0.0000
605 OROPHARYNGEAL PAIN 1 0.0000
606 HYPERSENSITIVITY 2 0.0000
607 CARDIAC DISORDER 1 0.0000
608 SYNCOPE 1 0.0000
609 CHEST DISCOMFORT 1 0.0000
610 OVERDOSE 2 0.0000
611 PNEUMONIA 3 0.0000
612 MALAISE 4 0.0000
613 DYSPNOEA 5 0.0000
614 PALPITATIONS 1 0.0000
615 DISEASE PROGRESSION 1 0.0000
616 VISUAL IMPAIRMENT 1 0.0000
617 FATIGUE 6 0.0000
618 DEHYDRATION 1 0.0000
619 VISION BLURRED 1 0.0000
620 PRODUCT DOSE OMISSION ISSUE 2 0.0000
621 HOSPITALISATION 1 0.0000
622 FALL 2 0.0000
623 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
624 MUSCLE SPASMS 1 0.0000
625 BLOOD GLUCOSE INCREASED 1 0.0000
626 PRURITUS 2 0.0000
627 WEIGHT DECREASED 1 0.0000
628 COUGH 1 0.0000
629 INJECTION SITE PAIN 1 0.0000